Alzheimer's Research UK

“It’s incredibly sad to watch anyone go through it, knowing that their memories and abilities are slowly slipping away. For me, a cure would mean hope.” This year, a team of 40 Aston Martin Lagonda Ltd employees proudly participated in the London Landmarks Half Marathon, wearing their customised vests in support of Alzheimer’s Research UK. They’ve raised over £25,000 for dementia research. Thank you so much team for supporting our mission #ForACure. 🧡 We asked them, “What would finding a cure for dementia mean for you?” Here’s what some of them shared: “A cure would mean people not having to go through the heartbreak of dementia, both for the people who have dementia and their families who have to see their loved one deteriorate in front of their eyes.” What would a cure for dementia mean to you? If you were one of the lucky ones to get a place in the London Landmarks Half Marathon ballot, then we would love for you to join our team. Kickstart your fundraising journey by taking two minutes today to set up your fundraising page using the link below. 👇 https://lnkd.in/eSB56irw

Recently, we’ve seen huge progress in dementia research, with new Alzheimer’s treatments becoming available that work by removing the build-up of a protein called amyloid, from the brain. But what’s next for the field? Listen to the latest episode from Inside Health which features Dr Emma Mead, Chief Scientific Officer of our Drug Discovery Institute in Oxford. Dr Mead discusses what future dementia treatments could look like and the need to focus efforts on developing treatments that tackle different aspects of Alzheimer’s disease. https://lnkd.in/e3AufDJu

Currently, only around 65% of people with dementia symptoms receive a diagnosis, often after a lengthy wait. We want to understand the experience of seeking and getting a diagnosis of dementia. This valuable insight will help us identify how to make the pathway and experience better. This is where we need you! We want to hear from people who've been diagnosed with dementia in the last three years, or who are currently seeking answers for memory and thinking concerns. We’d also like to hear from you, if you‘re supporting a friend, family member or loved one. The survey only takes around 20 minutes to complete. Those with dementia symptoms or a diagnosis can complete it alone, or with the help of someone else. You can take part in the survey here: https://bit.ly/4fs8kCV And do help us reach even more people living with a dementia diagnosis by tapping share.

We are delighted to announce that Alzheimer’s Research UK is one of four charities selected for The Telegraph's Christmas Charity Appeal 2024! The Appeal will be running from now until the end of January. Keep your eyes peeled for stories about the progress we’re making in dementia research and the inspiring people who are standing with us for a cure. 🧡 Read the launch piece here: https://lnkd.in/ewzsWE3x

This week, the Chancellor Rachel Reeves delivered the Autumn Budget for 2024. As the UK’s leading dementia research charity, we believe the government should take every opportunity to advance health and research, and the Budget this week was the first big chance for the new government to outline its plans. We’ve taken a look at some of the key announcements and what they mean for our mission towards a cure. Read more: https://lnkd.in/gyib8ejd

“Research must go on” Last week’s news about the Alzheimer’s drug donanemab not being available on the NHS is disappointing for many people. However, these drugs are only the beginning. Prof Afia Ali from University College London has shared her reaction to the news and why we must now build on this to progress. Read more about the future of Alzheimer’s treatments here 👇 https://lnkd.in/e85vpfv5 UCL

Join us for the biggest dementia research conference in the UK! 🔬 · Network with top experts · Discover the latest updates in dementia research · Understand your work's impact · Grow your career and opportunities Register here to attend #ARUKConf25 at the ICC Birmingham or online: https://lnkd.in/eM-HNe67

Our Chief Executive Hilary Evans-Newton was on the BBC Breakfast sofa this morning talking about the second Alzheimer's drug #donanemab being licenced for use in Britain. It's important that all experts in our field come together, including academics, doctors, the health system, government and regulators so as many people can access these treatments as possible.

Today a new drug for early-Alzheimer’s disease, donanemab, has been licensed in Britain by the Medicines and Healthcare products Regulatory Agency. However, it has not been given the green light for the NHS in England and Wales. This is incredibly disappointing. After decades of tireless research, we finally have two new Alzheimer’s treatments licensed in Britain. But we’re stuck in a deadlock. While these breakthroughs exist, people still can’t access them through our national health service. And we know more treatments are coming. NHS England has identified nearly 30 other dementia drugs that could be available by the end of the decade. This gives the government and NHS a crucial opportunity to transform how dementia is treated - just as Labour pledged in their manifesto. But despite our hard efforts, we still haven’t heard from the Health Secretary, Wes Streeting MP on how he plans to break this deadlock. It’s more urgent than ever that the government acts on their promise, and brings together stakeholders from the NHS, NICE - National Institute for Health and Care Excellence and industry so people affected by dementia don’t continue to miss out on innovative treatments. Head to our website to find out more about today’s news and how you can help ensure dementia is given the political priority it deserves. https://lnkd.in/e6nV2HVU

DigiFest blasts off! 🚀 Our employees had the opportunity to explore the latest trends and developments in the world of digital at Alzheimer’s Research UK’s very first DigiFest event in Cambridge on 17 and 18 October. Spanning two days, around 100 employees were treated to talks and interactive sessions led by members of our digital campaigns, web, social media and online fundraising teams. We were also joined by speakers from Twitter/X, Meta, Yonder Media, Ozone | Powering the Premium Web, Social for Good, Tale Digital Ltd, Sprout Social, Inc. and Spotify. Christian Hankins, Head of Digital, said: "I was so inspired by the passion and breadth of topics covered at our first ever DigiFest. The sessions ranged from best-in-class user experiences to truly engaging our supporters online. “We want to put digital at the heart of everything we do to make a real difference to our mission For A Cure. “We had amazing speakers, incredible energy, enthusiasm... and this is just the beginning."